identification of monogenic immunity defects responsible for severe forms of COVID-19 in previously healthy patients]
- Funded by Other funders (France)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19start year
-99Known Financial Commitments (USD)
$181,889.8Funder
Other funders (France)Principal Investigator
Jean-Laurent CASANOVAResearch Location
FranceLead Research Institution
Institut Imagine, ParisResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Immunity
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
The GENCOVID project aims to determine whether the severe forms of Covid-19 encountered in young and healthy people could be linked to monogenic mutations (an error in a single gene in an individual), present from birth and affecting the immunity. Identifying the genes involved could shed light on the mechanisms at work in these severe forms